Parallel Fluidics is a Boston, MA–based manufacturer of microfluidic devices that provides on-demand design and manufacturing services for scientific teams. Led by CEO Josh Gomes, the company supplies production-grade devices intended to accelerate discovery and shorten the path from concept to commercial microfluidic products. It serves organizations across life sciences verticals including diagnostics, drug discovery, precision medicine, sequencing, and cell therapy. The company plans to use the new funding to grow its on-demand design and manufacturing platform, expand its hardware and software solutions, and commercialize its new product, MV-2. Parallel Fluidics raised a $7M Seed round to support those initiatives. The round was led by J2 Ventures with participation from 8VC and Praxis. Parallel Fluidics is a Boston-based digital manufacturer of microfluidic devices founded in 2020 by Josh Gomes and Andy Harris. The company offers a rapid prototyping platform that it says cuts industry-standard microfluidic prototype turnaround from 3–4 weeks to two days. Parallel plans to use new funding to hire manufacturing and mechanical engineers and to further develop its capabilities and capacity. Financially, the company announced a $1.8M round of financing, bringing total funding to $2.0M since founding, including a $225k NSF SBIR grant. Its stated goal is to lower the barrier to microfluidic development and help researchers move products from lab to market. The company targets applications across point-of-care testing, genomics, diagnostics, drug development, and other life‑science fields.

Total raised

$9M

Funding rounds

2

Latest round

Seed

Latest activity

Nov 2024